Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) SHH

10.12

-0.09(-0.88%)

Updated at October 20 11:29AM

Currency In CNY

Valuation

Market Cap8.26B
Enterprise Value7.44B
P/E Ratio43.5
PEG Ratio-1.09
Price/Sales Ratio10.74
Price/Book Ratio3.52
Enterprise/Revenue9.71
Enterprise/EBITDA27.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.25
Operating Margin0.32

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue795.29M
Revenue/Share0.94
Gross Profit421.9M
EBITDA248.24M
Net Income206.79M
Diluted EPS0.25

Balance Sheet

Total Cash1.15B
Total Cash/Share1.38
Total Debt330.28M
Total Debt/Equity0.14
Current Ratio2.83
Book Value Per Share2.9

Price History

52-Week Change19.7
52-Week High12.51
52-Week Low6.94
Moving Average 50 Days10.87
Moving Average 200 Days9.28

Statistics

Average Volume27.22M
Shares Outstanding830.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.98
Payout Ratio0.43
Last Split Factor7:5
Last Split DateJuly 12, 2024